| Entry |
|
|---|
| Name |
Reviparin sodium (JAN);
Clivarine (TN) |
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
|
|---|
| Remark |
| Product (DG00150): | D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US> |
|
|---|
| Efficacy |
Anticoagulant, Antithrombin III activator |
|---|
| Comment |
Low molecular weight heparin (LMWH)
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB08 Reviparin
D03337 Reviparin sodium (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
D03337 Reviparin sodium
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
SERPINC1 (AT3)
D03337 Reviparin sodium (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
|
|---|
| Other DBs |
|
|---|
